Bayer CFO Werner Baumann poses during a news conference in Leverkusen February 28, 2012. Quarterly earnings at Germany's largest drugmaker Bayer missed expectations on low sales volumes at its chemicals division as it banks on new drug launches to lift earnings in coming year. REUTERS/Ina Fassbender

Full Story: Bayer eyes higher dividend: CFO in paper